|
Volumn 9, Issue 2, 2008, Pages 82-83
|
Does Canadian research investment relate to cancer burden?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOTECHNOLOGY;
BREAST CANCER;
CANADA;
CANCER CONTROL;
CANCER MORTALITY;
CANCER RESEARCH;
CANCER SURVIVAL;
COLORECTAL CANCER;
DRUG INDUSTRY;
FUNDING;
GOVERNMENT;
HEALTH CARE ORGANIZATION;
HEALTH CARE PLANNING;
HEMATOLOGIC MALIGNANCY;
INTERNATIONAL COOPERATION;
INVESTMENT;
KIDNEY CANCER;
LETTER;
LEUKEMIA;
LUNG CANCER;
PRIORITY JOURNAL;
PROSTATE CANCER;
PUBLIC HEALTH SERVICE;
SMOKING CESSATION;
STEM CELL TRANSPLANTATION;
UNITED KINGDOM;
UNITED STATES;
URINARY TRACT CANCER;
CANADA;
COST OF ILLNESS;
HEALTH CARE COSTS;
HUMANS;
INCIDENCE;
NEOPLASMS;
RESEARCH SUPPORT AS TOPIC;
|
EID: 38549161600
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(08)70007-X Document Type: Letter |
Times cited : (10)
|
References (9)
|